拉米夫定 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "拉米夫定" in Chinese language version.

refsWebsite

Global rank Chinese rank

17web.archive.org

1^st place

8nih.gov

4^th place

5^th place

4doi.org

2^nd place

23^rd place

2europa.eu

68^th place

209^th place

2books.google.com

3^rd place

8^th place

2semanticscholar.org

11^th place

332^nd place

1drugs.com

399^th place

208^th place

1catie.ca

low place

1handle.net

102^nd place

492^nd place

1stanford.edu

179^th place

275^th place

1aidsmap.com

low place

1fda.gov

447^th place

581^st place

1medsafe.govt.nz

low place

6,677^th place

1yale.edu

565^th place

664^th place

1uspto.gov

1,459^th place

1,685^th place

1aau.edu

low place

9,160^th place

1thebody.com

low place

aau.edu

Soderstrom J. National Institutes of Health: Moving Research from the Bench to the Bedside. 2003. （原始内容存档于2016-03-04）.

aidsmap.com

Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?. aidsmap. [2025-05-15]. （原始内容存档于2025-05-30）.

books.google.com

Therapy of Viral Infections Volume 15 of Topics in Medicinal Chemistry. Springer. 2015: 6. ISBN 9783662467596. （原始内容存档于2016-08-15）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 506. ISBN 9783527607495.

catie.ca

3TC (lamivudine, Epivir). Catie. 2014 [2022-08-22]. （原始内容存档于2025-05-30）.

doi.org

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D. Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation. Antiviral Therapy. 1999, 4 (1): 7–14. PMID 10682123. S2CID 35040816. doi:10.1177/135965359900400101 .
Kasırga E. Lamivudine resistance in children with chronic hepatitis B. World Journal of Hepatology. April 2015, 7 (6): 896–902. PMC 4411531 . PMID 25937866. doi:10.4254/wjh.v7.i6.896 .
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial. Antiviral Therapy. 2006, 11 (6): 761–770. PMID 17310820. S2CID 25783477. doi:10.1177/135965350601100608 .
Koziel MJ, Peters MG. Viral hepatitis in HIV infection. The New England Journal of Medicine. April 2007, 356 (14): 1445–1454. PMC 4144044 . PMID 17409326. doi:10.1056/NEJMra065142.

drugs.com

Lamivudine. The American Society of Health-System Pharmacists. [2016-07-31]. （原始内容存档于2016-06-02）.

europa.eu

ema.europa.eu

Epivir EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-11-29]. （原始内容存档于2020-11-27）.
Zeffix EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-11-28]. （原始内容存档于2020-11-12）.

fda.gov

accessdata.fda.gov

RHIGHLIGHTS OF PRESCRIBING INFORMATION LAMIVUDINE TABLETS USP (PDF). Micro Labs Limited. [2025-05-15]. （原始内容存档 (PDF)于2025-03-18）.

handle.net

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

medsafe.govt.nz

LAMIVUDINE/ZIDOVUDINE VIATRIS 150/300 (PDF). Viatris. [2025-05-15]. （原始内容存档 (PDF)于2025-05-30）.

nih.gov

ncbi.nlm.nih.gov

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D. Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation. Antiviral Therapy. 1999, 4 (1): 7–14. PMID 10682123. S2CID 35040816. doi:10.1177/135965359900400101 .
Kasırga E. Lamivudine resistance in children with chronic hepatitis B. World Journal of Hepatology. April 2015, 7 (6): 896–902. PMC 4411531 . PMID 25937866. doi:10.4254/wjh.v7.i6.896 .
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial. Antiviral Therapy. 2006, 11 (6): 761–770. PMID 17310820. S2CID 25783477. doi:10.1177/135965350601100608 .
Koziel MJ, Peters MG. Viral hepatitis in HIV infection. The New England Journal of Medicine. April 2007, 356 (14): 1445–1454. PMC 4144044 . PMID 17409326. doi:10.1056/NEJMra065142.
Lamivudine. Drugs and Lactation Database (LactMed®) [Internet]. [2025-05-15]. （原始内容存档于2025-02-06）.
Taylor, Katherine; Fritz, Kristina. Lamivudine. StatPearls [Internet]. 2024-02-28 [2025-05-15]. （原始内容存档于2024-04-18）.

dailymed.nlm.nih.gov

Epivir- lamivudine tablet, film coated Epivir- lamivudine solution. DailyMed. 2020-08-01 [2020-11-28]. （原始内容存档于2022-03-19）.
Epivir HBV- lamivudine tablet, film coated Epivir HBV- lamivudine solution. DailyMed. 2020-08-17 [2020-11-28]. （原始内容存档于2017-02-17）.

semanticscholar.org

api.semanticscholar.org

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D. Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation. Antiviral Therapy. 1999, 4 (1): 7–14. PMID 10682123. S2CID 35040816. doi:10.1177/135965359900400101 .
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial. Antiviral Therapy. 2006, 11 (6): 761–770. PMID 17310820. S2CID 25783477. doi:10.1177/135965350601100608 .

stanford.edu

hivdb.stanford.edu

Index. [2010-07-23]. （原始内容存档于2010-07-01）. Stanford University Drug Resistance Database.

thebody.com

Gilden D. The Wide-Ranging Effects of Nucleoside Analogs:A Look at Mitochondrial Toxicity. 2000. （原始内容存档于2016-09-16）.

uspto.gov

US Patent Office (PDF). （原始内容存档 (PDF)于2016-06-16）.

web.archive.org

Lamivudine. The American Society of Health-System Pharmacists. [2016-07-31]. （原始内容存档于2016-06-02）.
3TC (lamivudine, Epivir). Catie. 2014 [2022-08-22]. （原始内容存档于2025-05-30）.
Epivir- lamivudine tablet, film coated Epivir- lamivudine solution. DailyMed. 2020-08-01 [2020-11-28]. （原始内容存档于2022-03-19）.
Epivir HBV- lamivudine tablet, film coated Epivir HBV- lamivudine solution. DailyMed. 2020-08-17 [2020-11-28]. （原始内容存档于2017-02-17）.
Epivir EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-11-29]. （原始内容存档于2020-11-27）.
Zeffix EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-11-28]. （原始内容存档于2020-11-12）.
Therapy of Viral Infections Volume 15 of Topics in Medicinal Chemistry. Springer. 2015: 6. ISBN 9783662467596. （原始内容存档于2016-08-15）.
Index. [2010-07-23]. （原始内容存档于2010-07-01）. Stanford University Drug Resistance Database.
Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?. aidsmap. [2025-05-15]. （原始内容存档于2025-05-30）.
Lamivudine. Drugs and Lactation Database (LactMed®) [Internet]. [2025-05-15]. （原始内容存档于2025-02-06）.
Taylor, Katherine; Fritz, Kristina. Lamivudine. StatPearls [Internet]. 2024-02-28 [2025-05-15]. （原始内容存档于2024-04-18）.
RHIGHLIGHTS OF PRESCRIBING INFORMATION LAMIVUDINE TABLETS USP (PDF). Micro Labs Limited. [2025-05-15]. （原始内容存档 (PDF)于2025-03-18）.
LAMIVUDINE/ZIDOVUDINE VIATRIS 150/300 (PDF). Viatris. [2025-05-15]. （原始内容存档 (PDF)于2025-05-30）.
Hunting Down HIV. [2025-06-19]. （原始内容存档于2020-09-02）.
US Patent Office (PDF). （原始内容存档 (PDF)于2016-06-16）.
Soderstrom J. National Institutes of Health: Moving Research from the Bench to the Bedside. 2003. （原始内容存档于2016-03-04）.
Gilden D. The Wide-Ranging Effects of Nucleoside Analogs:A Look at Mitochondrial Toxicity. 2000. （原始内容存档于2016-09-16）.

yale.edu

medicine.yale.edu

Hunting Down HIV. [2025-06-19]. （原始内容存档于2020-09-02）.